INSM (STOCKS)
Insmed, Inc.
$125.553200
-6.726800 (-5.09%)
Prev close: $132.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William H. Lewis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $37,068.14M
- Employees
- 1,271
- P/E (TTM)
- -32.22
- P/B (TTM)
- 38.12
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.14B |
| Benefits Costs and Expenses | $2.01B |
| Cost Of Revenue | $188.22M |
| Costs And Expenses | $1.98B |
| Gross Profit | $949.42M |
| Operating Expenses | $1.79B |
| Selling, General, and Administrative Expenses | $893.59M |
| Research and Development | $860.85M |
| Operating Income/Loss | -$840.62M |
| Income/Loss From Continuing Operations After Tax | -$875.31M |
| Income/Loss From Continuing Operations Before Tax | -$869.11M |
| Income Tax Expense/Benefit | $6.21M |
| Income Tax Expense/Benefit, Deferred | -$27.00K |
| Net Income/Loss | -$875.31M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$875.31M |
| Net Income/Loss Available To Common Stockholders, Basic | -$875.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.10 |
| Diluted Earnings Per Share | -$4.10 |
| Basic Average Shares | 649,506,000 |
| Diluted Average Shares | 649,506,000 |
| Assets | $2.10B |
| Current Assets | $1.63B |
| Inventory | $142.38M |
| Other Current Assets | $1.49B |
| Noncurrent Assets | $468.65M |
| Fixed Assets | $107.22M |
| Other Non-current Assets | $361.43M |
| Liabilities | $1.35B |
| Current Liabilities | $438.74M |
| Accounts Payable | $74.56M |
| Wages | $61.58M |
| Other Current Liabilities | $302.61M |
| Noncurrent Liabilities | $906.33M |
| Long-term Debt | $546.77M |
| Other Non-current Liabilities | $359.56M |
| Equity | $757.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $757.49M |
| Liabilities And Equity | $2.10B |
| Net Cash Flow From Operating Activities | -$778.92M |
| Net Cash Flow From Operating Activities, Continuing | -$778.92M |
| Net Cash Flow From Investing Activities | -$82.79M |
| Net Cash Flow From Investing Activities, Continuing | -$82.79M |
| Net Cash Flow From Financing Activities | $123.96M |
| Net Cash Flow From Financing Activities, Continuing | $123.96M |
| Exchange Gains/Losses | -$1.81M |
| Net Cash Flow | -$739.56M |
| Net Cash Flow, Continuing | -$737.75M |
| Comprehensive Income/Loss | -$880.42M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$880.42M |
| Other Comprehensive Income/Loss | -$880.42M |
| Other Comprehensive Income/Loss Attributable To Parent | -$5.11M |